Based on their mechanism of action, these techniques to stimulate ferroptosis may be more effective for BRD4-deficient tumour cells because they can partly compensate for the insensitivity of ferroptosis caused by metabolism disorders due to the lack of BRD4 expression. This evidence concerns the gene BRD4 and Other metabolic disease.